Home » DRUG STOCKS SLIP; DISCOVERY PLUNGES ON DRUG DELAY
DRUG STOCKS SLIP; DISCOVERY PLUNGES ON DRUG DELAY
Drug stocks slipped into negative territory early Wednesday as Discovery Laboratories plunged on news that the FDA still won't approve its pediatric treatment Surfaxin.
Investors
Business Daily
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May